Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.520
+0.060 (2.44%)
At close: Jul 21, 2026, 4:00 PM EDT
2.530
+0.010 (0.40%)
After-hours: Jul 21, 2026, 7:34 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,771,511
Market Cap
285.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| Niagen Bioscience | 117 |
| SAB Biotherapeutics | 86 |
| Lineage Cell Therapeutics | 77 |
| InflaRx | 65 |
| Immuneering | 55 |
| Eledon Pharmaceuticals | 33 |
INDP News
- 5 days ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 25 days ago - Indaptus Therapeutics files to sell 18.86M shares of common stock for holders - TheFly
- 25 days ago - Indaptus Therapeutics Registration statement: Registration filing - Filings
- 4 weeks ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders - GlobeNewsWire
- 2 months ago - Indaptus Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Indaptus Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire